Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), have used artificial neural networks (ANNs) and DNA microarrays to successfully predict the clinical outcome of patients diagnosed with neuroblastoma (NB). The ANNs also identified a minimal set of 19 genes whose expression levels were closely associated with this clinical outcome.
Based on an improved understanding of bacteriophages – viruses that infect bacteria – scientists reporting in the Sept. 23 issue of the journal “Nature” believe they have discovered a potential new way to control drug-resistant bacteria, an increasingly worrisome public health problem.
What is non-science today may indeed become the science of tomorrow, & with these thoughts in mind the complacencies of both schools of thought must be shaken. (Michael Baum, Brit. Prof. Of Surgery; Journal of the Royal Society of Medicine, 80, June, 1987 336-337.)
Maintaining a youthful appearance is a goal for many of us – both men and women alike – as the years pass by we look at ways of preventing the onset of inevitable signs of aging. Thanks to an established range of treatments offered by LINE BREAKER, specialist in the provision of non-surgical procedures you can prevent the visible signs of aging.
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), launched a three-site consortium spanning Boston, Cleveland and Philadelphia that will work to improve the outcomes of organ transplantation.
Malaria research scientists from around the globe have published new insights into the international burden of malaria and what can be done about it. The new data are presented in a supplement to the American Journal of Tropical Medicine and Hygiene titled “The Intolerable Burden of Malaria II: What’s New What’s Needed”.
Researchers have developed a new genetic test that can help predict whether parents who have one child with the “isolated” form of cleft lip or palate are likely to have a second child with the same birth defect. Isolated clefts account for 70 percent of all cleft lip and palate cases.
Researchers from 12 medical centers in the United States and Canada, who have performed islet transplants in 86 patients with type 1 diabetes, published their results today in the first annual report of the Collaborative Islet Transplant Registry (CITR). The report (www.citregistry.org) analyzes many factors that can affect the outcome of this experimental procedure for people with severe or complicated type 1 diabetes.
HIV wreaks much of its damage by targeting the “orchestra conductor” of the immune system, a key class of T cells — CD4+ T cells — whose destructive relationship with HIV has been well-studied by AIDS researchers. More poorly understood has been the effect of HIV on another key class of immune cells, antibody-producing B cells. The malfunction of B cells in HIV-infected patients was first described more than 20 years ago by H. Clifford Lane, M.D., Anthony S. Fauci, M.D., and colleagues at the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH).
Researchers at the National Cancer Institute (NCI), one of
the National Institutes of Health, have found promising
evidence that immune cell transplant therapy can help
shrink tumors in patients with metastatic breast cancer.
Similar therapies, which also involve transplantation of
donated immune cells, have produced dramatic anti-tumor
effects in leukemias and lymphomas-cancers of the blood
and lymph, respectively. However, previous studies have
not proven that such therapies have clinical effects on
breast cancer.